author-photo

Luke B. Fletcher

Oregon Health & Science University

16

Papers

210

Citations

Citation Trend

Filter By

Papers (11) Sort By

Journal Conference Others

IDH Inhibitors in AML-Promise and Pitfalls.

2021 Current Hematologic Malignancy Reports
Show All
- Source
- Cite
- Save
Citations (1)
Graft-versus-host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations.

2021 American Journal of Transplantation
Show All
- Source
- Cite
- Save
Citations (1)
Profile of Quizartinib for the Treatment of Adult Patients with Relapsed/Refractory FLT3-ITD-Positive Acute Myeloid Leukemia: Evidence to Date

2020 Cancer management and research
Show All
- Source
- Cite
- Save
Citations (12)
Novel Approaches for Systemic Mastocytosis

2019 Current Opinion in Hematology
- Luke B. Fletcher
- Uma Borate
Show All
- Source
- Cite
- Save
Citations (4)
Abstract 1847: The ubiquitin proteasome system controls cell cycle gene expression through regulation of histone acetylation in multiple myeloma

2018 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening.

2013 Cancer Research
Show All
- Source
- Cite
- Save
Citations (118)
5.50 CX-4945, an Orally Bioavailable Selective Inhibitor of Protein Kinase CK2, Exhibits CLL Antitumor Activity

2011 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
CX-4945, An Orally Bioavailable Selective Inhibitor of Casein Kinase 2 (CK2), Exhibits Anti-Tumor Activity in Hematologic Malignancies,

2011 Blood
Show All
- Source
- Cite
- Save
Citations (0)
2.31 Phosphoinositide 3'-Kinase (PI3K) Delta Inhibition with CAL-101 (GS 1101) Significantly Alters Chemokines and Shows Increased In Vitro Activity in Unmutated IgVh CLL Compared to Mutated IgVh Samples

2011 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
P505-15, a Highly Selective SYK Inhibitor, Shows Significant Activity In Primary CLL Cells and Is Synergistic with Fludarabine at Low Concentrations

2010 Blood
Show All
- Source
- Cite
- Save
Citations (1)